DaVita Inc. ROE

ROE of DVA for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.


Highlights and Quick Summary

  • Annual ROE for 2022 was 61.85% (a -20.9% decrease from previous year)
  • Annual ROE for 2021 was 78.19% (a 96.36% increase from previous year)
  • Annual ROE for 2020 was 39.82% (a 52.92% increase from previous year)
  • Twelve month ROE ending June 30, 2023 was 47.21% (a -6.37% decrease compared to previous quarter)
  • Twelve month trailing ROE decreased by -29.5% year-over-year
Trailing ROE for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
47.21% 50.42% 61.85% 66.96%
Visit stockrow.com/DVA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of DaVita Inc.

Most recent ROEof DVA including historical data for past 10 years.

Interactive Chart of ROE of DaVita Inc.

DaVita Inc. ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 61.85%
2021 78.19%
2020 39.82%
2019 26.04%
2018 3.62%
2017 13.63%
2016 17.71%
2015 5.17%
2014 14.51%
2013 14.87%
2012 17.33%

Business Profile of DaVita Inc.

Sector: Healthcare
Industry: Medical Care Facilities